Inhalable aerogel shows promise for transmission-blocking COVID-19 vaccine

Posted: March 29, 2022

UNIVERSITY PARK, Pa. — An inhalable "aerogel" loaded with DNA that encodes for the SARS-CoV-2 spike protein successfully induces an immune response against COVID-19 in the lungs of mice, according to new research conducted at Penn State. The team said its aerogel could be used to create an inhalable vaccine that blocks SARS-CoV-2 transmission by preventing the virus from establishing an infection in the lungs.

https://www.psu.edu/news/research/story/inhalable-aerogel-shows-promise-transmission-blocking-covid-19-vaccine/?utm_audience=Combined&utm_source=newswire&utm_medium=email&utm_campaign=agricultural%20sciences%20newswire&utm_content=03-28-2022-07-06&utm_term=Stories%20-%203